CDC's Guidelines for Syphilis

Published On 2018-02-18 13:30 GMT   |   Update On 2018-02-18 13:30 GMT

Center for Disease Control and Prevention has come out with sexually transmitted diseases (STDs) treatment guidelines.These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC in 2015 after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30–May 2, 2013.They have been prepared by the NNPTC, NCSD, and ASTDA, with support from the CDC division of STD prevention.


Center for Disease Control and Prevention Guidelines for Syphilis.


Primary, secondary, early latent (1 year) syphilis:




  • Recommended regimen:- Benzathine penicillin G, 2.4 million units IM once.*



  • Alternative oral regimens (penicillin-allergic, non pregnant women):- Doxycycline 100 mg orally twice daily for 2 weeks.


Late latent, tertiary, and cardiovascular syphilis:




  • Recommended regimen:- Benzathine penicillin G, 2.4 million units IM weekly times 3 doses.



  • Alternative oral regimen (penicillin-allergic, non pregnant women):- Doxycycline 100 mg orally twice daily for 4 weeks.**


Neurosyphilis^




  • Drugs of choice: Penicillin G 3 -4 million units IV every 4 hours or 24 million units continuous IV infusion for 10 - 14 days [or]

  • Penicillin G procaine 2.4 million units IM daily + probenecid 500 mg 4 times daily oral, both for 10 - 14 days
    Alternatives

  • ceftriaxone 2 g IV once daily for 10 - 14 days


Congenital


Drugs of choice:




  • Penicillin G 50,000 units/kg every 8-12 hours for 10 -14 days [or]

  • Penicillin G procaine 50,000 units/kg IM daily for 10 -14 days


* Some experts recommend a repeat dose after seven days, especially in patients with HIV infection or pregnant women.


**Not recommended in pregnancy.


^patients allergic to penicillin should be desensitized and treated with penicillin.


For Further Reference log on to :


http://www.ncsddc.org/resource/2015-cdc-std-treatment-guidelines-summary-chart/

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News